Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
APYX
$2.90
+0.35%
APYX
· Apyx Medical Corp
Market Cap
$122.16M
Shares
42.12M
All earnings calls
Earnings call · FY2026 Q2
Apyx Medical Corp (APYX) Q2 2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$13.88M
+22.1% YoY
Gross margin
63.9%
+1.6 pp YoY
Net income
-$3.24M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
Initiated
year ending December 31, 2026
|
$59M – $60M | GAAP | |
|
OEM revenue
Initiated
year ending December 31, 2026
|
$5M | GAAP | |
|
Surgical Aesthetics revenue
Initiated
year ending December 31, 2026
|
$54M – $55M | GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document